Results 211 to 220 of about 102,606 (291)

Outcome parameters in studies investigating dry eye disease: A systematic literature review

open access: yesActa Ophthalmologica, EarlyView.
Abstract The development of effective therapeutics for dry eye disease (DED) is challenging due to its complex pathophysiology, heterogeneous patient presentation and the significant failure rate of previous clinical development programs. This underlines the importance of the selection of appropriate endpoints for clinical trials.
Viktoria Pai   +8 more
wiley   +1 more source

Bilateral corneal ulceration in ocular graft-versus-host disease

open access: gold, 2013
William Stevenson   +4 more
openalex   +2 more sources

Anterior chamber flare and central macular thickness after trabeculectomy versus after phacoemulsification

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To compare the inflammatory response in the eye after trabeculectomy to after phacoemulsification, focusing on anterior chamber flare (AC flare) and central macular thickness (CMT). Methods Data from 436 participants in two randomized controlled trials were analysed.
Yasmeen Ahmed   +5 more
wiley   +1 more source

A novel single-cell level evaluation method for corneal endothelial cell function. [PDF]

open access: yesNPJ Digit Med
Li D   +15 more
europepmc   +1 more source

Using continuous visual stimulus tracking for detecting visual function loss due to acquired brain injury

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Acquired brain injury (ABI) may cause homonymous visual field (VF) defects. Standard automated perimetry (SAP) is the gold standard for VF assessment, but it can be challenging in ABI. Continuous visual stimulus tracking (SONDA; Standardised Oculomotor and Neurological Disorders Assessment) simplifies the perimetric task to following a
A. C. L. Vrijling   +6 more
wiley   +1 more source

Gene editing for corneal disease management. [PDF]

open access: yesWorld J Transl Med, 2016
Raikwar SP   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy